Antibiotics

Our group focuses on hit identification and lead development in drug discovery. We work on targets of importance in infectious diseases with a focus on Gram-Negative infections, Tuberculosis and Malaria. In this work we are integrating computational medicinal chemistry tools with organic chemistry. We work in close collaboration with microbiologists, biochemists and structural biologists.

Contact Anders Karlén